ESOT Grants Recipients

Hall of ESOT Transplant Fellows
Hall of ESOT Transplant Fellows


  • Mr David Schibilsky M.D.&;s picture

    Mr David Schibilsky M.D.

    Hospital/Company: Papworth Hospital NHS Trust
    Office City: Papworth - Cambridgeshire
    Office Country: United Kingdom
    PERSONAL DETAILS Date/Place of Birth 25th July 1981 / Duisburg, Germany EDUCATION March 2016 - present: Cardiothoracic Surgeon, University Heart Center Tübingen March 2016: Board Certification Cardiac Surgery, Karlsruhe/Reutlingen, Germany June 2011 – March 2016: Resident in Thoracic and Cardiovascular Surgery, University Heart Center, Tübingen (Prof. Schlensak), Germany April/May 2013Research Fellowship: Cardiovascular Surgery, DeBakey Heart and Vascular Center, Houston, Texas, USA (ISHLT travel scholarship) November 2011 Clinical Fellowship (MCS): Cardiovascular Surgery, Heart-Center Bad Oeyenhausen, Germany October 2009 – May 2011Resident in Cardiovascular Surgery, University Heart Center Freiburg – Bad Krozingen (Prof. Beyersdorf), Germany April 2010 Doctoral Thesis (“Summa cum laude”/1.0), Freiburg, Germany September 2009 German Medical Licence (Grade: 2.0), Freiburg, Germany October 2004 – May 2009 Clinical part of medical studies: Albert-Ludwigs University Freiburg, Germany; & Mount Sinai Medical School, New York, USA September 2004 Preliminary Medical Examination (Grade 2.3), Würzburg, Germany October 2002 – September 2004 Pre-Clinical part of medical studies: Julius-Maximilians-University Würzburg RESEARCH EXPERIENCE Mai 2004 - present Clinical studies (GCP), first PI: SEE-HF: 2014 October 2008 - present Clinical and basic research projects, University Heart Centers Freiburg-Bad Krozingen and Tübingen April 2005 – May 2009 Basic Research: Department of Experimental Anaesthesiology, Freiburg, Germany (Doctoral thesis) LANGUAGES German: Native speaker English: Advanced INTERESTS /MEMBERSHIPS Profesional: Valve surgery, CABG, Mechanical circulatory support, Thoracic Transplantation, Scientometrics, Hemocompatibility, Reperfusion, Apoptosis Personal: Mountaineering, Sailing, Cycling, Photography Member: International Society of Heart and Lung Transplantation (ISHLT), European Association of Cardiothoracic Surgery (EACTS), German Society of Thoracic and Cardiovacular Surgery (DGTHG)
  • Dr. Francesca Tinti MD&;s picture

    Dr. Francesca Tinti MD

    Hospital/Company: Sapienza University of Rome
    Office City: Rome
    Office Country: Italy
    Dr. Tinti was trained at Sapienza University of Rome, Italy, (supervisor Prof. Anna Paola Mitterhofer). The scientific activity carried out by Dr. Tinti has always proved to be strongly in line with the clinical activity. She has always directed her interest to transplantation of abdominal organs, in particular kidney transplantation and liver transplantation, initially in collaboration with the surgeons of the Sapienza Transplant Centre, and subsequently in international research and collaboration programs with the Liver Transplant Unit and the Renal Unit at Queen Elizabeth University Hospital (Birmingham, UK). Participation in kidney and liver transplantation was associated with the follow-up of patients pre- and post-transplantation. Particular attention was paid to immunosuppressive therapy and its complications in particular viral infections, nephrotoxicity and adverse cardiovascular effects, different immunosuppression schemes and innovative pharmacological formulations. Dr. Tinti has developed over time an increasing interest in acute and chronic renal dysfunction in liver transplantation, focusing to study patients in the immediate post-transplantation and in the long-term follow-up. She has also developed an interest in the study and follow-up of renal function in patients with hepatitis C virus (HCV) infection, particularly in the use of new antiretroviral drugs. Lately, particular attention has been paid to the study and application of perfusion and maintenance techniques of the transplanted organs, in particular in the context of donation from deceased donors due to cardiocirculatory death. She recently completed the Doctoral project in hepatology, focusing on the role of ischaemia-reperfusion injury after liver transplantation affecting local and remote organs, with the development of biliary complications and acute kidney injury. The clinical experience during these years led her to achieve the European Diploma in Transplantation Medicine (UEMS), which required certified documentation of continuous and extensive training in all areas of transplant medicine, with specific participation in the evaluation of candidates for transplantation and post-transplant patient follow-up. Awarded with the ESOT Grant Transplant Fellowship (2017), she was also awarded with the Euroliver Foundation Award (2015) and several Travel Grants by EASL and ERA-EDTA. Former Chair of the Young Professionals in Transplantation (ESOT), she has been recently allowed as member of the European Board of Transplant Medicine (UEMS) as liason with young European group of transplant professional.


  • Miss Caroline DUDREUILH MD

    Hospital/Company: HENRI MONDOR
    Office City: CRETEIL
    Office Country: France
    I am a nephrologist with a special interest in immunology and transplantation. My passion for immunology and research led me to complete my medical degree with an intercalated research period enabling me to be awarded a bachelor of science in "Immunology" in addition to a national Master degree’s on the topic "Graft and Host Relation". My Master degree’s internship was hosted within the laboratory of Professor Dürrbach (Inserm unit U1014/UMR1197 "Stem cells, transplantation, immuno-regulation"). It was an opportunity for me to confirm my interest in research and strengthened my career goal; to become an academic nephrologist. Following my training in Tours and Paris (Clinical fellowship in Nephrology and Transplantation in Henri Mondor Hospital) I elected to apply for a position as a research assistant in the MRC Centre Transplantation (Kings College, London) in the group of Professor Lombardi, focusing on tolerance induction in transplantation trough adoptive transfer of regulatory T cells (Tregs). The lab is ideally situated within Guy’s Hospital, which has one of the largest transplantation programs in the UK and is internationally recognised as a centre of excellence, with a special expertise in transplantation for highly sensitised patients and ABO incompatible transplantation (Professor Dorling, Professor Mamode). The ESOT Transplant Fellowship is an incredible opportunity for me to improve my basic science knowledge within one of the top centre for transplant immunology worldwide, whilst working with some of the most experienced investigators in the field of transplant rejection and tolerance, with a particular focus on the contribution of the different subtypes of T and B cells.
  • Dr. Maria Meneghini

    Hospital/Company: IRCCS Cà Grande Ospedale Policlinico Milano
    Office City: Milan
    Office Country: Italy
    I am a medical doctor and I recently concluded my residency in Nephrology. During the 5 years of the residency program I had the possibility to practice in all areas of the nephrology specialization: clinical nephrology, management of acute and chronic kidney diseases, hemodialysis and peritoneal dialysis and, of course, kidney transplantation. I was particularly interested in this last topic and during the residency I could gain experience in the clinical management of kidney transplant patients both at Ospedale Policlinico in Milan and during a short clinical internship in Barcelona. The experience of the ESOT Transplant Fellowship would be the occasion to deepen my knowledge on kidney transplantation by having the chance of working one year in a European reference center where large numbers of all the most important types of kidney transplantation are performed. As the Spanish transplant system has recently been recognized as a very successful model by the international scientific community, the clinical experience in this center would be very useful for my future career. Moreover, in Italy some practices such as non-heart beating donors and ABO-incompatible transplantation are starting to grow in the last years, while in Spain a solid experience in such particular cases has already been developed. The approach to the management of transplant recipients both in the pre-transplant, early posttransplant and long term is similar in the two countries, being mostly assigned to the nephrologist. Therefore, an intensive training with the Bellvitge Kidney Transplant group would give me knowledge and skills to be used in Italy in the clinical setting.


  • Dr. Laurens Ceulemans MD, PhD

    Hospital/Company: University Hospitals Leuven
    Office City: Leuven
    Office Country: Belgium
    Dr. Ceulemans graduated in 2010 as medical doctor at the KU Leuven in Belgium. He started his training in general surgery at the University Hospitals Leuven and in parallel performed a PhD at the KU Leuven under supervision of professor Jacques Pirenne. His thesis (2017) focused on diagnosis and modulation of intestinal ischemia reperfusion injury in basic research models and immunological manipulation of clinical intestinal transplantation. Dr: Ceulemans published the results of his research in more than 30 peer-reviewed papers in high-impact journals. At the same time, he got strongly involved in the transplant community as board member of the Young Professionals in Transplantation workgroup (YPT; 2014-2017) and as board member of the Intestinal Rehabilitation and Transplantation Association (IRTA-TTS; 2017-2021). Over the last years, he has been granted several awards for his scientific contributions including the Horlait-Dapsens scholarship and European Society of Thoracic Surgeons (ESTS) biology club award. At the same time Dr. Ceulemans developed a specific interest in lung transplantation. After his graduation as general surgeon, he performed a fellowship in thoracic surgery and lung transplantation (2018) at the University Hospitals Leuven under supervision of professor Paul De Leyn and professor Dirk Van Raemdonck. His main topic of interest is ex-vivo lung perfusion (EVLP) and its potential as platform for reconditioning and immunomodulation. In 2019 Dr. Ceulemans performs a 6-month research and clinical fellowship at the UniversitätsSpital Zürich, Switzerland under supervision of professor Walter Weder where he investigates a rat model of EVLP and the potential of genetic manipulation. After this fellowship Dr. Ceulemans returns to Leuven where he will dedicate his career to the experimental and clinical lung transplantation program.
  • Dr. Hannah Esser

    Hospital/Company: Centre for Regenerative Medicine, Institute for Regeneration and Repair
    Office City: Edinburgh
    Office Country: United Kingdom
    Education: Albert-Ludwigs-University Freiburg, Germany (10/2008 – 05/2015) Internships/terms abroad: 02/2012 – 10/2012: Semester at the school of medicine of the University of Sao Paulo, Brazil (Faculdade de Medicina da Universidade de São Paulo); 09/2014 – 12/2014: Medical clerkship – Centre of Operative Medicine – Medical University Innsbruck, Austria; 01/2015 -04/2015: Medical clerkship – Department of Internal medicine - Katutura State Hospital Windhoek, Namibia Training: 08/2015 – 01/2018: Resident at the Department of Visceral, Transplant and Thoracic Surgery, Centre of Operative Medicine, Medical University of Innsbruck; 02/2018 - 08/2018: Fellow at the Scottish Liver Transplant Unit, Royal Infirmary of Edinburgh; 09/2018 - current: PhD in Surgery at the University of Edinburgh Research & Laboratory Experience: 03/2013 – 07/2017: Conclusion of the doctoral thesis “Clinical Outcomes after Patellar Fractures” at the Albert-Ludwigs-University Freiburg, Germany; 09/2015 – 01/2018: clinical research in the field of liver transplantation; Risk Factors in Orthotopic Liver Transplantation; Preoperative Assessment of Muscle Mass Using Computerized Tomography Scans to Predict Outcomes Following Orthotopic Liver Transplantation; Backtable Hepatic Artery Reconstruction in Orthotopic Liver Transplantation;Early Biliary Leakage Following Orthotopic Liver Transplantation; 06/2016 – 01/2018: Basic research at the D. Swarowski Laboratory in the field of ischemia reperfusion injury in transplantation utilizing a murine heterotopic heart transplantation model; 03/2018 – 08/2018: Basic research MRC Centre for Regenerative Medicine, University of Edinburgh (Supervisor Prof. Stuart Forbes); 09/2018 – current: PhD in Surgery at the MRC Centre for Regenerative Medicine, University of Edinburgh Honors & Awards: 2nd price Austrian “Young Surgeon Forum”2016: Austrian Surgical Association, SalzburgJungforscherpreis/ experimentell 2017 (Co-author): Austrian Transplant Society, Zell am See.


  • Mr Ilker Iskender MD, MSc

    Hospital/Company: University Hospitals Leuven
    Office City: Leuven
    Office Country: Belgium
    Ilker Iskender is a thoracic surgeon from Turkey. He has a special interest in lung transplantation and is currently working within the Department of Thoracic Surgery at the University Hospitals Leuven as a surgical fellow. After completion of a residency program in Istanbul, Turkey, he first went to Toronto, Canada to expand his scientific skills in the field of lung transplantation. He received a Master of Science degree from the University of Toronto in 2014. Thereafter, He has registered as a medical practitioner in the United Kingdom and I worked as a cardiothoracic retrieval fellow at the Queen Elizabeth Hospital Birmingham. Following the UK training, he has appointed as a registrar at the University Hospital Zurich, Switzerland between 2017 and 2019. He has published more than 20 peer reviewed articles and speaks English and German fluently. He aims to complete his training in Leuven, Belgium and become a surgeon-scientist focusing on the treatment of end stage lung diseases.
  • Dr. Thomas Jouve MD, PhD

    Hospital/Company: Grenoble-Alpes University Hospital
    Office City: Grenoble Cedex 9
    Office Country: France
    I am a transplant physician at Grenoble-Alpes University Hospital, France. I am currently an assistant professor in the Nephrology unit. My research interests focus on kidney transplantation epidemiology and the evaluation of the immune response while under immuno-suppressive drugs. Using pharmacokinetics, pharmacodynamics and immunology tools, my aim is to assess the immune response as precisely as possible to guide our prescriptions. Given our local desensitization program in kidney transplantation, I try to apply these tools to highly immuno-depressed patients. The goal is to get a better picture of immune function and immune reconstitution during and after desensitization and kidney transplantation. I also have a strong interest in Teaching and participate in students&; training and education, daily by teaching residents, but also by teaching medical students. As of November of 2020, I will have the opportunity to investigate the immune reconstitution following desensitization protocols in the lab of Oriol Bestard, at Bellvitge Hospital in Barcelona (Spain). I have the good fortune to be the recipient of a Transplant Fellowship Funding from the ESOT itself and am very looking forward to working on this topic together with the team in Barcelona ! We will also have the opportunity to work with the team of Farsad Eskandari, Georg Böhmig and Pr Rainer Oberbauer, also focusing on their desensitized patients. This European project is very promising and exciting !